Skip to main content

Table 1 Demographic and clinic characteristics

From: The effects of dexmedetomidine on thiol/disulphide homeostasis in coronary artery bypass surgery: a randomized controlled trial

 

Group D

n = 30

Group C

n = 30

p

Age (year)*

61 ± 9.43

62.43 ± 8.23

0,533

Sex (n)

  

0.774

Female/Male

8/22

9/21

BMI (kg/m2 )*

27.18 ± 3.91

27.27 ± 4.33

0.940

Duration of cross clamp *

(minute)

51.37 ± 14.25

51.03 ± 14.74

0.929

Duration of CPB pump*

(minute)

82.03 ± 18.69

81.53 ± 24.61

0.930

Duration of surgery *

(minute)

242.70 ± 42.05

253.47 ± 42.40

0.328

Comorbidity(n)

COPD

4

2

0.389

Diabetes mellitus

16

13

0.438

Hypertension

15

17

0.605

Renal disease

1

0

0.313

Remifentanil consumption* (mg)

1.80 ± 0.17

1.84 ± 0.21

0.366

Dexmedetomidine consumption* (mcg)

146.57 ± 19.52

0

< 0.001

  1. CPB: Cardiopulmonary Bypass; COPD: Chronic obstructive pulmonary disease
  2. *: Mean ± Standard Deviation; p < 0.05 was considered significant